We profiled the activity of BBO-8520, a covalent dual inhibitor of GTP-bound (ON) and GDP-bound (OFF) KRAS <sup>G12C</sup> , in <i>KRAS <sup>G12C</sup></i> -mutant non-small cell lung cancer models. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.